These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3839050)

  • 1. Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy.
    Bonomini V; Frascà GM; Raimondi C; Liviano D'arcangelo G; Vangelista A
    Nephron; 1985; 40(2):195-200. PubMed ID: 3839050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of defibrotide in acute renal failure due to thrombotic microangiopathy.
    Vangelista A; Frascà GM; Raimondi C; Liviano-D'Arcangelo G; Bonomini V
    Haemostasis; 1986; 16 Suppl 1():51-4. PubMed ID: 3754836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of vascular graft lesions in renal transplant recipients with a new antithrombotic agent (defibrotide): a controlled study.
    Frascà GM; Vangelista A; Raimondi C; Bonomini V
    Life Support Syst; 1986; 4(3):231-7. PubMed ID: 3537545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.
    Palmer KJ; Goa KL
    Drugs; 1993 Feb; 45(2):259-94. PubMed ID: 7681375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new antithrombotic agent in the treatment of acute renal failure due to hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.
    Bonomini V; Vangelista A; Frascà G
    Nephron; 1984; 37(2):144. PubMed ID: 6547211
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphometric and ultrastructural study of experimental venous thrombosis. Effects of defibrotide, an antithrombotic agent.
    Fumagalli G; Angelaccio E; Lombardo N; Clementi F
    Haemostasis; 1987; 17(6):361-70. PubMed ID: 3428723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic enhancement in diabetic microangiopathy with defibrotide.
    Belcaro G; Marelli C; Pomante P; Laurora G; Cesarone MR; Ricci A; Girardello R; Barsotti A
    Angiology; 1992 Oct; 43(10):793-800. PubMed ID: 1476266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrotide therapy for thrombophlebitis--controlled clinical trial.
    Di Perri T; Vittoria A; Messa GL; Cappelli R
    Haemostasis; 1986; 16 Suppl 1():42-7. PubMed ID: 3754835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology and mode of action of a new antithrombotic compound: Defibrotide.
    Ulutin ON; Cizmeci G; Balkuv-Ulutin S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):177-80. PubMed ID: 2459016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of defibrotide for prophylaxis of deep venous thrombosis after general surgery: a double-blind, placebo-controlled clinical trial.
    Mozzi E; Chiurazzi D; Germiniani R; Pacini F
    Haemostasis; 1986; 16 Suppl 1():36-8. PubMed ID: 3519382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrotide in extracorporeal circulation on healthy rabbits.
    Marsili M; Lorenzi P; Librenti M; Doni L; Benassai C; Martini E; Fabbri LP; Cinotti S; Morfini M; Boncinelli S
    Int J Artif Organs; 1989 Dec; 12(12):749-54. PubMed ID: 2613355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange.
    Beşişik SK; Oztürk GB; Calişkan Y; Sargin D
    Turk J Gastroenterol; 2005 Mar; 16(1):34-7. PubMed ID: 16252186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study.
    Coccheri S; Andreozzi GM; D'Addato M; Gensini GF;
    Int Angiol; 2004 Jun; 23(2):100-7. PubMed ID: 15507885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of defibrotide for prophylaxis of deep venous thrombosis in gynecological surgery: a double-blind, placebo-controlled clinical trial.
    Ciavarella N; Ettorre C; Schiavoni M; Schonauer S; Cicinelli E; Cagnazzo G
    Haemostasis; 1986; 16 Suppl 1():39-41. PubMed ID: 3754834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of walking distance by defibrotide in patients with intermittent claudication--results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study.
    Violi F; Marubini E; Coccheri S; Nenci GG
    Thromb Haemost; 2000 May; 83(5):672-7. PubMed ID: 10823260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of anti-Xa activity during combined defibrotide-heparin administration in hemodialysis.
    Buccianti G; Valenti G; Lorenz M; Cresseri D; Strada E; Nazzari M
    Int J Artif Organs; 1990 Jul; 13(7):416-20. PubMed ID: 2401580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure and severe hypertension in children with renal thrombotic microangiopathy.
    Bhuyan UN; Bagga A; Srivastava RN
    Nephron; 1994; 66(3):302-6. PubMed ID: 8190182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits.
    Paul W; Gresele P; Momi S; Bianchi G; Page CP
    Br J Pharmacol; 1993 Dec; 110(4):1565-71. PubMed ID: 8306102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of defibrotide in renal transplantation in man.
    Bonomini V; Vangelista A; Stefoni S; Scolari MP; Frascà GM; Raimondi C
    Haemostasis; 1986; 16 Suppl 1():48-50. PubMed ID: 3519383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.